Osteoarthritis of the knee

L Sharma - New England Journal of Medicine, 2021 - Mass Medical Soc
Key Clinical Points Osteoarthritis of the Knee Potential long-term consequences of knee
osteoarthritis include reduced physical activity, deconditioning, impaired sleep, fatigue …

Emerging pharmaceutical therapies for osteoarthritis

A Latourte, M Kloppenburg, P Richette - Nature Reviews Rheumatology, 2020 - nature.com
The prevalence of osteoarthritis (OA) and the burden associated with the disease are
steadily increasing worldwide, representing a major public health challenge for the coming …

[HTML][HTML] OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis

RR Bannuru, MC Osani, EE Vaysbrot, NK Arden… - Osteoarthritis and …, 2019 - Elsevier
Objective To update and expand upon prior Osteoarthritis Research Society International
(OARSI) guidelines by developing patient-focused treatment recommendations for …

Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology

RA Swarm, JA Paice, DL Anghelescu, M Are… - Journal of the National …, 2019 - jnccn.org
In recent years, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for
Adult Cancer Pain have undergone substantial revisions focusing on the appropriate and …

Thiazole ring—A biologically active scaffold

A Petrou, M Fesatidou, A Geronikaki - Molecules, 2021 - mdpi.com
Background: Thiazole is a good pharmacophore nucleus due to its various pharmaceutical
applications. Its derivatives have a wide range of biological activities such as antioxidant …

Novel treatment strategies in rheumatoid arthritis

GR Burmester, JE Pope - The Lancet, 2017 - thelancet.com
New treatment strategies have substantially changed the course of rheumatoid arthritis.
Many patients can achieve remission if the disease is recognised early and is treated …

Cardiovascular effects and safety of (non-aspirin) NSAIDs

AM Schjerning, P McGettigan, G Gislason - Nature Reviews Cardiology, 2020 - nature.com
Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective, widely used analgesics. For
the past 2 decades, considerable attention has been focused on their cardiovascular safety …

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout

R Hansildaar, D Vedder, M Baniaamam… - The Lancet …, 2021 - thelancet.com
The increased risk of cardiovascular morbidity and mortality in rheumatoid arthritis and gout
has been increasingly acknowledged in past decades, with accumulating evidence that …

Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials

CO Stiller, P Hjemdahl - Journal of Internal Medicine, 2022 - Wiley Online Library
Nonsteroidal anti‐inflammatory drugs (NSAIDs) inhibit the enzyme cyclooxygenase (COX),
which forms prostaglandins involved in pain and inflammation. COX inhibitors have …

Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say?

C Cooper, R Chapurlat, N Al-Daghri… - Drugs & aging, 2019 - Springer
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to
treat pain in osteoarthritis. While measured to have a moderate effect on pain in …